Immune control of Staphylococcus aureus - Regulation and counter-regulation of the adaptive immune response

International Journal of Medical Microbiology

Volumn 304, Issue 2, 2014, Pages 204-214

  Bröker, Barbara M ^a   Holtfreter, Silva ^a   Bekeredjian Ding, Isabelle ^b  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Antibodies; B cells; Immune memory; Staphylococcus aureus; T cells

Indexed keywords

ANTIBODIES; B CELLS; IMMUNE MEMORY; STAPHYLOCOCCUS AUREUS; T CELLS;

ADAPTIVE IMMUNITY; ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84893731331     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2013.11.008     Document Type: Short Survey

References (191)

1. Aalberse R.C., Stapel S.O., Schuurman J., Rispens T. Immunoglobulin G4: an odd antibody. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 2009, 39:469-477.
2. Acha-Orbea H., Shakhov A.N., Finke D. Immune response to MMTV infection. Frontiers in Bioscience: A Journal and Virtual Library 2007, 12:1594-1609.
3. Adhikari R.P., Ajao A.O., Aman M.J., Karauzum H., Sarwar J., Lydecker A.D., Johnson J.K., Nguyen C., Chen W.H., Roghmann M.C. Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections. Journal of Infectious Diseases 2012, 206:915-923.
4. Alonzo F., Kozhaya L., Rawlings S.A., Reyes-Robles T., DuMont A.L., Myszka D.G., Landau N.R., Unutmaz D., Torres V.J. CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature 2013, 493:51-55.
5. Anderson A.L., Sporici R., Lambris J., Larosa D., Levinson A.I. Pathogenesis of B-cell superantigen-induced immune complex-mediated inflammation. Infection and Immunity 2006, 74:1196-1203.
6. Arad G., Levy R., Nasie I., Hillman D., Rotfogel Z., Barash U., Supper E., Shpilka T., Minis A., Kaempfer R. Binding of superantigen toxins into the CD28 homodimer interface is essential for induction of cytokine genes that mediate lethal shock. PLoS Biology 2011, 9:e1001149.
7. Archer N., Harro J., Shirtliff M. Clearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influx. Infection and Immunity 2013, 81:2070-2075.
8. Atkins K.L., Burman J.D., Chamberlain E.S., Cooper J.E., Poutrel B., Bagby S., Jenkins A.T., Feil E.J., van den Elsen J.M. S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation. Molecular Immunology 2008, 45:1600-1611.
9. Bachert C., van Steen K., Zhang N., Holtappels G., Cattaert T., Maus B., Buhl R., Taube C., Korn S., Kowalski M., Bousquet J., Howarth P. Specific IgE against Staphylococcus aureus enterotoxins: an independent risk factor for asthma. Journal of Allergy and Clinical Immunology 2012, 130. 376-381, e378.
10. Bardoel B.W., Strijp J.A. Molecular battle between host and bacterium: recognition in innate immunity. Journal of Molecular Recognition 2011, 24:1077-1086.
11. Barnes P.J. Intrinsic asthma: Not so different from allergic asthma but driven by superantigens?. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 2009, 39:1145-1151.
12. Becker K., Friedrich A.W., Lubritz G., Weilert M., Peters G., von Eiff C. Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. Journal of Clinical Microbiology 2003, 41.
13. Bekeredjian-Ding I., Inamura S., Giese T., Moll H., Endres S., Sing A., Zahringer U., Hartmann G. Staphylococcus aureus protein A triggers T cell-independent B cell proliferation by sensitizing B cells for TLR2 ligands. Journal of Immunology 2007, 178:2803-2812.
14. Belkaid Y., Rouse B.T. Natural regulatory T cells in infectious disease. Nature Immunology 2005, 6:353-360.
15. Benson M.A., Lilo S., Nygaard T., Voyich J.M., Torres V.J. Rot and SaeRS cooperate to activate expression of the staphylococcal superantigen-like exoproteins. Journal of Bacteriology 2012, 194:4355-4365.
16. Benson M.A., Lilo S., Wasserman G.A., Thoendel M., Smith A., Horswill A.R., Fraser J., Novick R.P., Shopsin B., Torres V.J. Staphylococcus aureus regulates the expression and production of the staphylococcal superantigen-like secreted proteins in a Rot-dependent manner. Molecular Microbiology 2011, 81:659-675.
17. Berberian L., Goodglick L., Kipps T.J., Braun J. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 1993, 261:1588-1591.
18. Bertin P.A., Marti G.E. Expression of immunoglobulin heavy chain variable gene (VH) in B-chronic lymphocytic leukemia (B-CLL) and B-prolymphocytic leukemia (B-PLL) cell lines. "Restricted" usage of VH3 family. Annals of the New York Academy of Sciences 1992, 651:464-466.
19. Berube B.J., Bubeck Wardenburg J. Staphylococcus aureus alpha-toxin: nearly a century of intrigue. Toxins 2013, 5:1140-1166.
20. Bestebroer J., De Haas C.J., Van Strijp J.A. How microorganisms avoid phagocyte attraction. FEMS Microbiology Reviews 2010, 34:395-414.
21. Bode L.G., Kluytmans J.A., Wertheim H.F., Bogaers D., Vandenbroucke-Grauls C.M., Roosendaal R., Troelstra A., Box A.T., Voss A., van der Tweel I., van Belkum A., Verbrugh H.A., Vos M.C. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. New England Journal of Medicine 2010, 362:9-17.
22. Bouvet J.P., Marone G. Protein Fv: an endogenous immunoglobulin superantigen and superallergen. Chemical Immunology and Allergy 2007, 93:58-76.
23. Bröker B.M., van Belkum A. Immune proteomics of Staphylococcus aureus. Proteomics 2011, 11:3221-3231.
24. Brons R.H., Bakker H.I., Van Wijk R.T., Van Dijk N.W., Muller Kobold A.C., Limburg P.C., Manson W.L., Kallenberg C.G., Tervaert J.W. Staphylococcal acid phosphatase binds to endothelial cells via charge interaction: A pathogenic role in Wegener's granulomatosis?. Clinical and Experimental Immunology 2000, 119:566-573.
25. Buckley R.H. Pulmonary complications of primary immunodeficiencies. Paediatric Respiratory Reviews 2004, 5(Suppl. A):S225-S233.
26. Burman J.D., Leung E., Atkins K.L., O'Seaghdha M.N., Lango L., Bernado P., Bagby S., Svergun D.I., Foster T.J., Isenman D.E., van den Elsen J.M. Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus. Journal of Biological Chemistry 2008, 283:17579-17593.
27. Burnet F.M.A. A modification of Jerne's theory of antibody production using the concept of clonal selection. Australian Journal of Medical Science 1957, 20:67-69.
28. Cerutti A., Cols M., Gentile M., Cassis L., Barra C.M., He B., Puga I., Chen K. Regulation of mucosal IgA responses: lessons from primary immunodeficiencies. Annals of the New York Academy of Sciences 2011, 1238:132-144.
29. Chabelskaya S., Gaillot O., Felden B. A Staphylococcus aureus small RNA is required for bacterial virulence and regulates the expression of an immune-evasion molecule. PLoS Pathogens 2010, 6:e1000927.
30. Chandesris M.O., Melki I., Natividad A., Puel A., Fieschi C., Yun L., Thumerelle C., Oksenhendler E., Boutboul D., Thomas C., Hoarau C., Lebranchu Y., Stephan J.L., Cazorla C., Aladjidi N., Micheau M., Tron F., Baruchel A., Barlogis V., Palenzuela G., Mathey C., Dominique S., Body G., Munzer M., Fouyssac F., Jaussaud R., Bader-Meunier B., Mahlaoui N., Blanche S., Debre M., Le Bourgeois M., Gandemer V., Lambert N., Grandin V., Ndaga S., Jacques C., Harre C., Forveille M., Alyanakian M.A., Durandy A., Bodemer C., Suarez F., Hermine O., Lortholary O., Casanova J.L., Fischer A., Picard C. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine 2012, 91:e1-e19.
31. Cheung A.L., Eberhardt K., Heinrichs J.H. Regulation of protein A synthesis by the sar and agr loci of Staphylococcus aureus. Infection and Immunity 1997, 65:2243-2249.
32. Cho J.S., Pietras E.M., Garcia N.C., Ramos R.I., Farzam D.M., Monroe H.R., Magorien J.E., Blauvelt A., Kolls J.K., Cheung A.L., Cheng G., Modlin R.L., Miller L.S. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. Journal of Clinical Investigation 2010, 120:1762-1773.
33. Clarke S.R., Brummell K.J., Horsburgh M.J., McDowell P.W., Mohamad S.A., Stapleton M.R., Acevedo J., Read R.C., Day N.P., Peacock S.J., Mond J.J., Kokai-Kun J.F., Foster S.J. Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. Journal of Infectious Diseases 2006, 193:1098-1108.
34. Colque-Navarro P., Jacobsson G., Andersson R., Flock J.I., Mollby R. Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population. Clinical and Vaccine Immunology 2010, 17:1117-1123.
35. Colque-Navarro P., Palma M., Soderquist B., Flock J.I., Mollby R. Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein. Clinical and Diagnostic Laboratory Immunology 2000, 7:14-20.
36. Colque-Navarro P., Soderquist B., Holmberg H., Blomqvist L., Olcen P., Mollby R. Antibody response in Staphylococcus aureus septicaemia - a prospective study. Journal of Medical Microbiology 1998, 47:217-225.
37. Cook M.C., Tangye S.G. Primary immune deficiencies affecting lymphocyte differentiation: lessons from the spectrum of resulting infections. International Immunology 2009, 21:1003-1011.
38. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clinical Infectious Diseases 2003, 36:53-59.
39. Craven D.E. Staphylococcus aureus colonisation and bacteraemia in persons infected with human immunodeficiency virus: a dynamic interaction with the host. Journal of Chemotherapy 1995, 7(3):19-28.
40. Crum-Cianflone N., Weekes J., Bavaro M. Recurrent community-associated methicillin-resistant Staphylococcus aureus infections among HIV-infected persons: incidence and risk factors. AIDS Patient Care and STDs 2009, 23:499-502.
41. Darenberg J., Ihendyane N., Sjolin J., Aufwerber E., Haidl S., Follin P., Andersson J., Norrby-Teglund A., Group S.S. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clinical Infectious Diseases 2003, 37:333-340.
42. Daum R.S., Spellberg B. Progress toward a Staphylococcus aureus vaccine. Clinical Infectious Diseases 2012, 54:560-567.
43. David M.Z., Daum R.S. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clinical Microbiology Reviews 2010, 23:616-687.
44. de Kraker M.E., Wolkewitz M., Davey P.G., Koller W., Berger J., Nagler J., Icket C., Kalenic S., Horvatic J., Seifert H., Kaasch A.J., Paniara O., Argyropoulou A., Bompola M., Smyth E., Skally M., Raglio A., Dumpis U., Kelmere A.M., Borg M., Xuereb D., Ghita M.C., Noble M., Kolman J., Grabljevec S., Turner D., Lansbury L., Grundmann H. Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrobial Agents and Chemotherapy 2011, 55:1598-1605.
45. DeDent A.C., McAdow M., Schneewind O. Distribution of protein A on the surface of Staphylococcus aureus. Journal of Bacteriology 2007, 189:4473-4484.
46. Demengeot J., Zelenay S., Moraes-Fontes M.F., Caramalho I., Coutinho A. Regulatory T cells in microbial infection. Springer Seminars in Immunopathology 2006, 28:41-50.
47. Dryla A., Prustomersky S., Gelbmann D., Hanner M., Bettinger E., Kocsis B., Kustos T., Henics T., Meinke A., Nagy E. Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clinical and Diagnostic Laboratory Immunology 2005, 12:387-398.
48. Espersen F., Frimodt-Moller N., Rosdahl V.T., Jessen O., Faber V., Rosendal K. Staphylococcus aureus bacteremia in patients with hematological malignancies and/or agranulocytosis. Acta Medica Scandinavica 1987, 222:465-470.
49. Eyerich K., Pennino D., Scarponi C., Foerster S., Nasorri F., Behrendt H., Ring J., Traidl-Hoffmann C., Albanesi C., Cavani A. IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response. Journal of Allergy and Clinical Immunology 2009, 123. 59-66 e54.
50. Fais F., Ghiotto F., Hashimoto S., Sellars B., Valetto A., Allen S.L., Schulman P., Vinciguerra V.P., Rai K., Rassenti L.Z., Kipps T.J., Dighiero G., Schroeder H.W., Ferrarini M., Chiorazzi N. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. Journal of Clinical Investigation 1998, 102:1515-1525.
51. Faria N.A., Carrico J.A., Oliveira D.C., Ramirez M., de Lencastre H. Analysis of typing methods for epidemiological surveillance of both methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. Journal of Clinical Microbiology 2008, 46:136-144.
52. Fillatreau S. Novel regulatory functions for Toll-like receptor-activated B cells during intracellular bacterial infection. Immunological Reviews 2011, 240:52-71.
53. Fillatreau S. Cytokine-producing B cells as regulators of pathogenic and protective immune responses. Annals of the Rheumatic Diseases 2013, 72(2):ii80-ii84.
54. Fleischer B., Schrezenmeier H. T-cell stimulation by Staphylococcal enterotoxins - clonally variable response and requirement for major histocompatibility complex class-Ii molecules on accessory or target-cells. Journal of Experimental Medicine 1988, 167:1697-1707.
55. Frank K.M., Zhou T., Moreno-Vinasco L., Hollett B., Garcia J.G., Bubeck Wardenburg J. Host response signature to Staphylococcus aureus alpha-hemolysin implicates pulmonary Th17 response. Infection and Immunity 2012, 80:3161-3169.
56. Fraser J., Arcus V., Kong P., Baker E., Proft T. Superantigens - powerful modifiers of the immune system. Molecular Medicine Today 2000, 6:125-132.
57. Fraser J.D., Proft T. The bacterial superantigen and superantigen-like proteins. Immunological Reviews 2008, 225:226-243.
58. Fritz S.A., Tiemann K.M., Hogan P.G., Epplin E.K., Rodriguez M., Al-Zubeidi D.N., Bubeck Wardenburg J., Hunstad D.A. A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection. Clinical Infectious Diseases 2013, 56:1554-1561.
59. Gaffen S.L. Recent advances in the IL-17 cytokine family. Current Opinion in Immunology 2011, 23:613-619.
60. Geiger R., Duhen T., Lanzavecchia A., Sallusto F. Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells. Journal of Experimental Medicine 2009, 206:1525-1534.
61. Goodyear C.S., Silverman G.J. Death by a B cell superantigen: in vivo VH-targeted apoptotic supraclonal B cell deletion by a staphylococcal toxin. Journal of Experimental Medicine 2003, 197:1125-1139.
62. Graille M., Stura E.A., Corper A.L., Sutton B.J., Taussig M.J., Charbonnier J.B., Silverman G.J. Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:5399-5404.
63. Grumann D., Nubel U., Broker B.M. Staphylococcus aureus toxins - their functions and genetics. Infection, Genetics and Evolution 2013, pii: S1567-1348(13)00086-5 [Epub ahead of print]. 10.1016/j.meegid.2013.03.013.
64. Grumann D., Ruotsalainen E., Kolata J., Kuusela P., Jarvinen A., Kontinen V.P., Broker B.M., Holtfreter S. Characterization of infecting strains and superantigen-neutralizing antibodies in Staphylococcus aureus bacteremia. Clinical and Vaccine Immunology 2011, 18:487-493.
65. Guermonprez P., Valladeau J., Zitvogel L., Thery C., Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annual Review of Immunology 2002, 20:621-667.
66. Hammarstrom L., Granstrom M., Oxelius V., Persson M.A., Smith C.I. IgG subclass distribution of antibodies against S. aureus teichoic acid and alpha-toxin in normal and immunodeficient donors. Clinical and Experimental Immunology 1984, 55:593-601.
67. Hammarstrom L., Persson M.A., Smith C.I. Subclass distribution of human anti-Staphylococcus aureus alpha toxin antibodies: suggestion of an IgG1, IgA1, IgG4 switch pattern. Scandinavian Journal of Immunology 1984, 20:247-250.
68. Hjelm H., Sjodahl J., Sjoquist J. Immunologically active and structurally similar fragments of protein A from Staphylococcus aureus. European Journal of Biochemistry 1975, 57:395-403.
69. Hohmann A., Cairns E., Brisco M., Bell D.A., Diamond B. Immunoglobulin gene sequence analysis of anti-cardiolipin and anti-cardiolipin idiotype (H3) human monoclonal antibodies. Autoimmunity 1995, 22:49-58.
70. Holtfreter S., Grumann D., Schmudde M., Nguyen H.T., Eichler P., Strommenger B., Kopron K., Kolata J., Giedrys-Kalemba S., Steinmetz I., Witte W., Bröker B.M. Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates. Journal of Clinical Microbiology 2007, 45:2669-2680.
71. Holtfreter S., Kolata J., Broker B.M. Towards the immune proteome of Staphylococcus aureus - the anti-S. aureus antibody response. International Journal of Medical Microbiology 2010, 300:176-192.
72. Holtfreter S., Nguyen T.T., Wertheim H., Steil L., Kusch H., Truong Q.P., Engelmann S., Hecker M., Volker U., van Belkum A., Broker B.M. Human immune proteome in experimental colonization with Staphylococcus aureus. Clinical and Vaccine Immunology 2009, 16:1607-1614.
73. Holtfreter S., Roschack K., Eichler P., Eske K., Holtfreter B., Kohler C., Engelmann S., Hecker M., Greinacher A., Broker B.M. Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis. Journal of Infectious Diseases 2006, 193:1275-1278.
74. Hooper L.V., Littman D.R., Macpherson A.J. Interactions between the microbiota and the immune system. Science 2012, 336:1268-1273.
75. Horvath R., Rozkova D., Lastovicka J., Polouckova A., Sedlacek P., Sediva A., Spisek R. Expansion of T helper type 17 lymphocytes in patients with chronic granulomatous disease. Clinical and Experimental Immunology 2011, 166:26-33.
76. Huang S.C., Jiang R., Hufnagle W.O., Furst D.E., Wilske K.R., Milner E.C. VH usage and somatic hypermutation in peripheral blood B cells of patients with rheumatoid arthritis (RA). Clinical and Experimental Immunology 1998, 112:516-527.
77. Huvenne W., Hellings P.W., Bachert C. Role of staphylococcal superantigens in airway disease. International Archives of Allergy and Immunology 2013, 161:304-314.
78. Ishigame H., Kakuta S., Nagai T., Kadoki M., Nambu A., Komiyama Y., Fujikado N., Tanahashi Y., Akitsu A., Kotaki H., Sudo K., Nakae S., Sasakawa C., Iwakura Y. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009, 30:108-119.
79. Jacobsson G., Colque-Navarro P., Gustafsson E., Andersson R., Mollby R. Antibody responses in patients with invasive Staphylococcus aureus infections. European Journal of Clinical Microbiology and Infectious Diseases 2010, 29:715-725.
80. Joshi A., Pancari G., Cope L., Bowman E.P., Cua D., Proctor R.A., McNeely T. Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model. Human Vaccines and Immunotherapeutics 2012, 8:336-346.
81. Kahl B.C. Small colony variants (SCVs) of Staphylococcus aureus - a bacterial survival strategy. Infection, Genetics and Evolution 2013, pii: S1567-1348(13)00205-0 [Epub ahead of print]. 10.1016/j.meegid.2013.05.016.
82. Kallenberg C.G. What is the evidence for prophylactic antibiotic treatment in patients with systemic vasculitides?. Current Opinion in Rheumatology 2011, 23:311-316.
83. Kim M.R., Hong S.W., Choi E.B., Lee W.H., Kim Y.S., Jeon S.G., Jang M.H., Gho Y.S., Kim Y.K. Staphylococcus aureus-derived extracellular vesicles induce neutrophilic pulmonary inflammation via both Th1 and Th17 cell responses. Allergy 2012, 67:1271-1281.
84. Kisich K.O., Carspecken C.W., Fieve S., Boguniewicz M., Leung D.Y. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. Journal of Allergy and Clinical Immunology 2008, 122:62-68.
85. Klein U., Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nature Reviews Immunology 2008, 8:22-33.
86. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Ray S., Harrison L.H., Lynfield R., Dumyati G., Townes J.M., Craig A.S., Zell E.R., Fosheim G.E., McDougal L.K., Carey R.B., Fridkin S.K. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of the American Medical Association 2007, 298:1763-1771.
87. Kolata J., Bode L.G., Holtfreter S., Steil L., Kusch H., Holtfreter B., Albrecht D., Hecker M., Engelmann S., van Belkum A., Völker U., Bröker B.M. Distinctive patterns in the human antibody response to Staphylococcus aureus bacteremia in carriers and non-carriers. Proteomics 2011, 11:3914-3927.
88. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 Cells. Annual Review of Immunology 2009, 27:485-517.
89. Kozlowski L.M., Li W., Goldschmidt M., Levinson A.I. In vivo inflammatory response to a prototypic B cell superantigen: elicitation of an Arthus reaction by staphylococcal protein A. Journal of Immunology 1998, 160:5246-5252.
90. Kudva A., Scheller E.V., Robinson K.M., Crowe C.R., Choi S.M., Slight S.R., Khader S.A., Dubin P.J., Enelow R.I., Kolls J.K., Alcorn J.F. Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. Journal of Immunology 2011, 186:1666-1674.
91. Laarman A., Milder F., van Strijp J., Rooijakkers S. Complement inhibition by Gram-positive pathogens: molecular mechanisms and therapeutic implications. Journal of Molecular Medicine (Berl.) 2010, 88:115-120.
92. Lam T.T., Giese B., Chikkaballi D., Kuhn A., Wolber W., Pane-Farre J., Schafer D., Engelmann S., Fraunholz M., Sinha B. Phagolysosomal integrity is generally maintained after Staphylococcus aureus invasion of nonprofessional phagocytes but is modulated by strain 6850. Infection and Immunity 2010, 78:3392-3403.
93. Lampropoulou V., Calderon-Gomez E., Roch T., Neves P., Shen P., Stervbo U., Boudinot P., Anderton S.M., Fillatreau S. Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity. Immunological Reviews 2010, 233:146-161.
94. Langley R., Patel D., Jackson N., Clow F., Fraser J.D. Staphylococcal superantigen super-domains in immune evasion. Critical Reviews in Immunology 2010, 30:149-165.
95. Langley R., Wines B., Willoughby N., Basu I., Proft T., Fraser J.D. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria. Journal of Immunology 2005, 174:2926-2933.
96. Laudien M., Gadola S.D., Podschun R., Hedderich J., Paulsen J., Reinhold-Keller E., Csernok E., Ambrosch P., Hellmich B., Moosig F., Gross W.L., Sahly H., Lamprecht P. Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener s granulomatosis as compared to rheumatoid arthritis and chronic Rhinosinusitis with nasal polyps. Clinical and Experimental Rheumatology 2010, 28:51-55.
97. Lauvau G., Glaichenhaus N. Mini-review: presentation of pathogen-derived antigens in vivo. European Journal of Immunology 2004, 34:913-920.
98. Lederman H.M., Winkelstein J.A. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine 1985, 64:145-156.
99. Lee A.H., Levinson A.I., Schumacher H.R. Hypogammaglobulinemia and rheumatic disease. Seminars in Arthritis and Rheumatism 1993, 22:252-264.
100. Leshem E., Maayan-Metzger A., Rahav G., Dolitzki M., Kuint J., Roytman Y., Goral A., Novikov I., Fluss R., Keller N., Regev-Yochay G. Transmission of Staphylococcus aureus from mothers to newborns. Pediatric Infectious Disease Journal 2012, 31:360-363.
101. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., Fouser L.A. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. Journal of Experimental Medicine 2006, 203:2271-2279.
102. Lin L., Ibrahim A.S., Xu X., Farber J.M., Avanesian V., Baquir B., Fu Y., French S.W., Edwards J.E., Spellberg B. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathogens 2009, 5:e1000703.
103. Lindberg E., Adlerberth I., Hesselmar B., Saalman R., Strannegard I.L., Aberg N., Wold A.E. High rate of transfer of Staphylococcus aureus from parental skin to infant gut flora. Journal of Clinical Microbiology 2004, 42:530-534.
104. Lindberg E., Nowrouzian F., Adlerberth I., Wold A.E. Long-time persistence of superantigen-producing Staphylococcus aureus strains in the intestinal microflora of healthy infants. Pediatric Research 2000, 48:741-747.
105. Lindmark R., Movitz J., Sjoquist J. Extracellular protein A from a methicillin-resistant strain of Staphylococcus aureus. European Journal of Biochemistry 1977, 74:623-628.
106. Löffler B., Tuchscherr L., Niemann S., Peters G. Staphylococcus aureus persistence in non-professional phagocytes. International Journal of Medical Microbiology 2014, [E-pub ahead of print]. 10.1016/j.ijmm.2013.11.011.
107. Lorenz U., Ohlsen K., Karch H., Thiede A., Hacker J. Immunodominant proteins in human sepsis caused by methicillin resistant Staphylococcus aureus. Advances in Experimental Medicine and Biology 2000, 485:273-278.
108. Lowy F.D. Staphylococcus aureus infections. New England Journal of Medicine 1998, 339:520-532.
109. Mainiero M., Goerke C., Geiger T., Gonser C., Herbert S., Wolz C. Differential target gene activation by the Staphylococcus aureus two-component system saeRS. Journal of Bacteriology 2010, 192:613-623.
110. Majlessi L., Lo-Man R., Leclerc C. Regulatory B and T cells in infections. Microbes and Infection 2008, 10:1030-1035.
111. Manfredi R., Calza L., Chiodo F. Epidemiology and microbiology of cellulitis and bacterial soft tissue infection during HIV disease: a 10-year survey. Journal of Cutaneous Pathology 2002, 29:168-172.
112. Mauri C., Bosma A. Immune regulatory function of B cells. Annual Review of Immunology 2012, 30:221-241.
113. McCarthy A.J., Lindsay J.A. Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: implications for vaccine design and host-pathogen interactions. BMC Microbiology 2010, 10:173.
114. McCormick J.K., Yarwood J.M., Schlievert P.M. Toxic shock syndrome and bacterial superantigens: an update. Annual Review of Microbiology 2001, 55:77-104.
115. McGeachy M.J., McSorley S.J. Microbial-induced Th17: Superhero or supervillain?. Journal of Immunology 2012, 189:3285-3291.
116. McHeyzer-Williams M., Okitsu S., Wang N., McHeyzer-Williams L. Molecular programming of B cell memory. Nature Reviews Immunology 2012, 12:24-34.
117. Miethke T., Wahl C., Heeg K., Wagner H. Superantigens: the paradox of T-cell activation versus inactivation. International Archives of Allergy and Immunology 1995, 106:3-7.
118. Miller L.S., Cho J.S. Immunity against Staphylococcus aureus cutaneous infections. Nature Reviews Immunology 2011, 11:505-518.
119. Milner J.D., Brenchley J.M., Laurence A., Freeman A.F., Hill B.J., Elias K.M., Kanno Y., Spalding C., Elloumi H.Z., Paulson M.L., Davis J., Hsu A., Asher A.I., O'Shea J., Holland S.M., Paul W.E., Douek D.C. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008, 452:773-776.
120. Monteil M.A., Kaniuk A.S., Hobbs J.R. Staphylococcal opsonization and anti-Staphylococcus aureus IgG subclass antibodies in patients with severe or recurrent S. aureus infections. FEMS Microbiology Immunology 1990, 2:259-262.
121. Morgan B.P. Complement. Fundamental Immunology 2013, 863-890. Lippincott Williams & Wilkins, Philadelphia. 7th ed. W.E. Paul (Ed.).
122. Morrison V.A. The infectious complications of chronic lymphocytic leukemia. Seminars in Oncology 1998, 25:98-106.
123. Movitz J. Formation of extracellular protein A by Staphylococcus aureus. European Journal of Biochemistry 1976, 68:291-299.
124. Narita K., Hu D.L., Mori F., Wakabayashi K., Iwakura Y., Nakane A. Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A. Infection and Immunity 2010, 78:4234-4242.
125. Nimmerjahn F., Ravetch J.V. Fcgamma receptors as regulators of immune responses. Nature Reviews Immunology 2008, 8:34-47.
126. Nygaard T.K., Pallister K.B., DuMont A.L., DeWald M., Watkins R.L., Pallister E.Q., Malone C., Griffith S., Horswill A.R., Torres V.J., Voyich J.M. Alpha-toxin induces programmed cell death of human T cells, B cells, and monocytes during USA300 infection. PLoS ONE 2012, 7:e36532.
127. O'hea J. Helper T-cell differentiation and plasticity. Fundamental Immunology 2013, 708-717. Lippincott Williams & Wilkins, Philadelphia. 7th ed. W.E. Paul (Ed.).
128. Orange J.S., Jain A., Ballas Z.K., Schneider L.C., Geha R.S., Bonilla F.A. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. Journal of Allergy and Clinical Immunology 2004, 113:725-733.
129. Orange J.S., Levy O., Brodeur S.R., Krzewski K., Roy R.M., Niemela J.E., Fleisher T.A., Bonilla F.A., Geha R.S. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia. Journal of Allergy and Clinical Immunology 2004, 114:650-656.
130. Palmqvist N., Silverman G.J., Josefsson E., Tarkowski A. Bacterial cell wall-expressed protein A triggers supraclonal B-cell responses upon in vivo infection with Staphylococcus aureus. Microbes and Infection 2005, 7:1501-1511.
131. Pantrangi M., Singh V.K., Wolz C., Shukla S.K. Staphylococcal superantigen-like genes, ssl5 and ssl8, are positively regulated by Sae and negatively by Agr in the Newman strain. FEMS Microbiology Letters 2010, 308:175-184.
132. Parcina M., Miranda-Garcia M.A., Durlanik S., Ziegler S., Over B., Georg P., Foermer S., Ammann S., Hilmi D., Weber K.J., Schiller M., Heeg K., Schneider-Brachert W., Gotz F., Bekeredjian-Ding I. Pathogen-triggered activation of plasmacytoid dendritic cells induces IL-10-producing B cells in response to Staphylococcus aureus. Journal of Immunology 2013, 190:1591-1602.
133. Parcina M., Wendt C., Goetz F., Zawatzky R., Zahringer U., Heeg K., Bekeredjian-Ding I. Staphylococcus aureus-induced plasmacytoid dendritic cell activation is based on an IgG-mediated memory response. Journal of Immunology 2008, 181:3823-3833.
134. Pastacaldi C., Lewis P., Howarth P. Staphylococci and staphylococcal superantigens in asthma and rhinitis: a systematic review and meta-analysis. Allergy 2011, 66:549-555.
135. Patel D., Wines B.D., Langley R.J., Fraser J.D. Specificity of staphylococcal superantigen-like protein 10 toward the human IgG1 Fc domain. Journal of Immunology 2010, 184:6283-6292.
136. Paul W.E. The immune system. Fundamental Immunology 2013, 1-21. Lippincott Williams & Wilkins, Philadelphia. 7th ed. W.E. Paul (Ed.).
137. Peled J.U., Kuang F.L., Iglesias-Ussel M.D., Roa S., Kalis S.L., Goodman M.F., Scharff M.D. The biochemistry of somatic hypermutation. Annual Review of Immunology 2008, 26:481-511.
138. Perotti M., Ghidoli N., Altara R., Diotti R.A., Clementi N., De Marco D., Sassi M., Clementi M., Burioni R., Mancini N. Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia. Autoimmunity Reviews 2008, 7:468-472.
139. Popa E.R., Stegeman C.A., Abdulahad W.H., van der Meer B., Arends J., Manson W.M., Bos N.A., Kallenberg C.G., Tervaert J.W. Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis. Rheumatology 2007, 46:1029-1033.
140. Proctor R.A. Is there a future for a Staphylococcus aureus vaccine?. Vaccine 2012, 30:2921-2927.
141. Projan S.J., Nesin M., Dunman P.M. Staphylococcal vaccines and immunotherapy: To dream the impossible dream?. Current Opinion in Pharmacology 2006, 6:473-479.
142. Prokesova L., Potuznikova B., Potempa J., Zikan J., Radl J., Hachova L., Baran K., Porwit-Bobr Z., John C. Cleavage of human immunoglobulins by serine proteinase from Staphylococcus aureus. Immunology Letters 1992, 31:259-265.
143. Reddy E.A., Shaw A.V., Crump J.A. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infectious Diseases 2010, 10:417-432.
144. Renner E.D., Rylaarsdam S., Anover-Sombke S., Rack A.L., Reichenbach J., Carey J.C., Zhu Q., Jansson A.F., Barboza J., Schimke L.F., Leppert M.F., Getz M.M., Seger R.A., Hill H.R., Belohradsky B.H., Torgerson T.R., Ochs H.D. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. Journal of Allergy and Clinical Immunology 2008, 122:181-187.
145. Rodriguez-Pinto D. B cells as antigen presenting cells. Cellular Immunology 2005, 238:67-75.
146. Roifman C.M., Chin K., Gazit A., Mills G.B., Gilon C., Levitzki A. Tyrosine phosphorylation is an essential event in the stimulation of B lymphocytes by Staphylococcus aureus Cowan I. Journal of Immunology 1991, 146:2965-2971.
147. Romagnani S., Amadori A., Giudizi M.G., Biagiotti R., Maggi E., Ricci M. Different mitogenic activity of soluble and insoluble staphylococcal protein A (SPA). Immunology 1978, 35:471-478.
148. Romagnani S., Guidizi M.G., Biagiotti R., Almerigogna F., Del Prete G.F., Maggi E., Ricci M. Protein A reactivity of lymphocytes from some patients with chronic lymphocytic leukaemia mediated by an interaction with the F(ab')2 region of surface immunoglobulin. Scandinavian Journal of Immunology 1982, 15:287-295.
149. Ryding U., Christensson B., Soderquist B., Wadstrom T. Antibody response to Staphylococcus aureus collagen binding protein in patients with S. aureus septicaemia and collagen binding properties of corresponding strains. Journal of Medical Microbiology 1995, 43:328-334.
150. Saiki O., Kawamoto M., Fukuzumi M., Kanou M., Utsumi S. Staphylococcus aureus Wood 46 strain activates human B cells without affecting DNA synthesis or tyrosine phosphorylation. Journal of Immunology 1993, 150:3224-3229.
151. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
152. Savage D.G., Lindenbaum J., Garrett T.J. Biphasic pattern of bacterial infection in multiple myeloma. Annals of Internal Medicine 1982, 96:47-50.
153. Schneewind O., Fowler A., Faull K.F. Structure of the cell wall anchor of surface proteins in Staphylococcus aureus. Science 1995, 268:103-106.
154. Senn M.M., Bischoff M., von Eiff C., Berger-Bachi B. sigmaB activity in a Staphylococcus aureus hemB mutant. Journal of Bacteriology 2005, 187:7397-7406.
155. Shen P., Lampropoulou V., Stervbo U., Hilgenberg E., Ries S., Mecqinion A., Fillatreau S. Intrinsic Toll-like receptor signalling drives regulatory function in B cells. Frontiers in Bioscience (Elite Ed) 2013, 5:78-86.
156. Shimada T., Park B.G., Wolf A.J., Brikos C., Goodridge H.S., Becker C.A., Reyes C.N., Miao E.A., Aderem A., Gotz F., Liu G.Y., Underhill D.M. Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion. Cell Host and Microbe 2010, 7:38-49.
157. Siakantaris M.P., Pangalis G.A., Dimitriadou E., Kontopidou F.N., Vassilakopoulos T.P., Kalpadakis C., Sachanas S., Yiakoumis X., Korkolopoulou P., Kyrtsonis M.C., Bobotsis P., Androulaki A., Patsouris E., Panayiotidis P., Angelopoulou M.K. Early-stage gastric MALT lymphoma: Is it a truly localized disease?. Oncologist 2009, 14:148-154.
158. Skurnik D., Merighi M., Grout M., Gadjeva M., Maira-Litran T., Ericsson M., Goldmann D.A., Huang S.S., Datta R., Lee J.C., Pier G.B. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice. Journal of Clinical Investigation 2010, 120:3220-3233.
159. Smith E.J., Corrigan R.M., van der Sluis T., Grundling A., Speziale P., Geoghegan J.A., Foster T.J. The immune evasion protein Sbi of Staphylococcus aureus occurs both extracellularly and anchored to the cell envelope by binding lipoteichoic acid. Molecular Microbiology 2012, 83:789-804.
160. Smith E.J., Visai L., Kerrigan S.W., Speziale P., Foster T.J. The Sbi protein is a multifunctional immune evasion factor of Staphylococcus aureus. Infection and Immunity 2011, 79:3801-3809.
161. Stavnezer J., Guikema J.E., Schrader C.E. Mechanism and regulation of class switch recombination. Annual Review of Immunology 2008, 26:261-292.
162. Stolz S., Davis J., Vergeront J., Crass B., Chesney P., Wand P., Bergdoll M. Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin. Journal of Infectious Diseases 1985, 151:883-889.
163. Trombetta E.S., Mellman I. Cell biology of antigen processing in vitro and in vivo. Annual Review of Immunology 2005, 23:975-1028.
164. Tuchscherr L., Medina E., Hussain M., Volker W., Heitmann V., Niemann S., Holzinger D., Roth J., Proctor R.A., Becker K., Peters G., Loffler B. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Molecular Medicine 2011, 3:129-141.
165. van Belkum A. Staphylococcal colonization and infection: homeostasis versus disbalance of human (innate) immunity and bacterial virulence. Current Opinion in Infectious Diseases 2006, 19:339-344.
166. van der Kooi-Pol M.M., de Vogel C.P., Westerhout-Pluister G.N., Veenstra-Kyuchukova Y.K., Duipmans J.C., Glasner C., Buist G., Elsinga G.S., Westra H., Bonarius H.P., Groen H., van Wamel W.J., Grundmann H., Jonkman M.F., van Dijl J.M. High anti-staphylococcal antibody titers in patients with epidermolysis bullosa relate to long-term colonization with alternating types of Staphylococcus aureus. Journal of Investigative Dermatology 2013, 133:847-850.
167. van der Kooi-Pol M.M., Duipmans J.C., Jonkman M.F., van Dijl J.M. Host-pathogen interactions in epidermolysis bullosa patients colonized with Staphylococcus aureus. International Journal of Medical Microbiology 2014, [E-pub ahead of print]. 10.1016/j.ijmm.2013.11.012.
168. Verkaik N.J., Boelens H.A., de Vogel C.P., Tavakol M., Bode L.G., Verbrugh H.A., van Belkum A., van Wamel W.J. Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia. European Journal of Clinical Microbiology and Infectious Diseases 2010, 29:509-518.
169. Verkaik N.J., de Vogel C.P., Boelens H.A., Grumann D., Hoogenboezem T., Vink C., Hooijkaas H., Foster T.J., Verbrugh H.A., van Belkum A., van Wamel W.J. Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. Journal of Infectious Diseases 2009, 199:625-632.
170. Verkaik N.J., Lebon A., de Vogel C.P., Hooijkaas H., Verbrugh H.A., Jaddoe V.W., Hofman A., Moll H.A., van Belkum A., van Wamel W.J. Induction of antibodies by Staphylococcus aureus nasal colonization in young children. Clinical Microbiology and Infection 2010, 16:1312-1317.
171. von Bernuth H., Picard C., Puel A., Casanova J.L. Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans. European Journal of Immunology 2012, 42:3126-3135.
172. von Eiff C., Becker K., Machka K., Stammer H., Peters G. Nasal Carriage as a source of Staphylococcus aureus bacteremia. New England Journal of Medicine 2001, 344:11-16.
173. von Eiff C., Peters G., Becker K. The small colony variant (SCV) concept - the role of staphylococcal SCVs in persistent infections. Injury 2006, 37(2):S26-S33.
174. Voswinkel J., Muller A., Lamprecht P. Is PR3-ANCA formation initiated in Wegener's granulomatosis lesions? Granulomas as potential lymphoid tissue maintaining autoantibody production. Annals of the New York Academy of Sciences 2005, 1051:12-19.
175. Wadhwa P.D., Morrison V.A. Infectious complications of chronic lymphocytic leukemia. Seminars in Oncology 2006, 33:240-249.
176. Weill J.C., Weller S., Reynaud C.A. Human marginal zone B cells. Annual Review of Immunology 2009, 27:267-285.
177. Wertheim H.F., Vos M.C., Ott A., van Belkum A., Voss A., Kluytmans J.A., van Keulen P.H., Vandenbroucke-Grauls C.M., Meester M.H., Verbrugh H.A. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004, 364:703-705.
178. Wertheim H.F.L., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., Verbrugh H.A., Nouwen J.I. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infection 2005, 5:751-762.
179. Whisler R.L., Grants I.S. Age-related alterations in the activation and expression of phosphotyrosine kinases and protein kinase C (PKC) among human B cells. Mechanisms of Ageing and Development 1993, 71:31-46.
180. Wilke G.A., Bubeck Wardenburg J. Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:13473-13478.
181. Wines B.D., Willoughby N., Fraser J.D., Hogarth P.M. A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptor, Fc alphaRI, is revealed by SSL7 binding at the C alpha2/C alpha3 interface of IgA. Journal of Biological Chemistry 2006, 281:1389-1393.
182. Wolf A.J., Arruda A., Reyes C.N., Kaplan A.T., Shimada T., Shimada K., Arditi M., Liu G., Underhill D.M. Phagosomal degradation increases TLR access to bacterial ligands and enhances macrophage sensitivity to bacteria. Journal of Immunology 2011, 187:6002-6010.
183. Xu S.X., McCormick J.K. Staphylococcal superantigens in colonization and disease. Frontiers in Cellular and Infection Microbiology 2012, 2:52.
184. Young A.E., Thornton K.L. Toxic shock syndrome in burns: diagnosis and management. Archives of Disease in Childhood. Education and Practice Edition 2007, 92:ep97-ep100.
185. Zhang L., Jacobsson K., Vasi J., Lindberg M., Frykberg L. A second IgG-binding protein in Staphylococcus aureus. Microbiology 1998, 144(Pt 4):985-991.
186. Zhang L., Rosander A., Jacobsson K., Lindberg M., Frykberg L. Expression of staphylococcal protein Sbi is induced by human IgG. FEMS Immunology and Medical Microbiology 2000, 28:211-218.
187. Zhu J., Paul W.E. Heterogeneity and plasticity of T helper cells. Cell Research 2010, 20:4-12.
188. Ziegler C., Goldmann O., Hobeika E., Geffers R., Peters G., Medina E. The dynamics of T cells during persistent Staphylococcus aureus infection: from antigen-reactivity to in vivo anergy. EMBO Molecular Medicine 2011, 3:652-666.
189. Zielinski C.E., Mele F., Aschenbrenner D., Jarrossay D., Ronchi F., Gattorno M., Monticelli S., Lanzavecchia A., Sallusto F. Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 2012, 484:514-518.
190. Zipfel P., Skerka C. Staphylococcus aureus: the multi headed hydra resists and controls human complement response in multiple ways. International Journal of Medical Microbiology 2014, [E-pub ahead of print]. 10.1016/j.ijmm.2013.11.004.
191. Zycinska K., Wardyn K.A., Zielonka T.M., Demkow U., Traburzynski M.S. Chronic crusting, nasal carriage of Staphylococcus aureus and relapse rate in pulmonary Wegener's granulomatosis. Journal of Physiology and Pharmacology 2008, 59(6):825-831.